SCHEMBL2689564

SCHEMBL2689564

COc1ccc2cc(Br)c(=O)oc2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.64
CA9 Q16790 3/20 0.64
CA2 P00918 3/20 0.64
CA1 P00915 2/20 0.64
ALDH1A1 P00352 5/20 0.61
MAOB P27338 5/20 0.61
HPGD P15428 4/20 0.61
GAA P10253 4/20 0.61
GLA P06280 4/20 0.61
SLC16A3 O15427 1/20 0.61
MEN1 O00255 1/20 0.61
KMT2A Q03164 1/20 0.61
KDM4E B2RXH2 5/20 0.60
HSD17B10 Q99714 2/20 0.60
CA3 P07451 2/20 0.60
CA4 P22748 2/20 0.60
CA6 P23280 2/20 0.60
CA7 P43166 2/20 0.60
CA14 Q9ULX7 2/20 0.60
NPC1 O15118 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9057890 0.87 CA2 (0.64) CA12CA9CA2CA1ALDH1A1
SCHEMBL15842248 0.81 ALDH1A1 (0.63) CA12CA9CA2CA1ALDH1A1
SCHEMBL10305766 0.81 ALDH1A1 (0.63) CA12CA9CA2CA1ALDH1A1
SCHEMBL28724124 0.80 CA12 (0.65) CA12CA9CA2CA1ALDH1A1
SCHEMBL8787053 0.80 ALDH1A1 (0.61) CA12CA9CA2CA1ALDH1A1
SCHEMBL28081400 0.80 ALDH1A1 (0.61) CA12CA9CA2CA1ALDH1A1
SCHEMBL4041859 0.80 CA12 (0.64) CA12CA9CA2CA1ALDH1A1
SCHEMBL17768961 0.80 ALDH1A1 (0.61) CA12CA9CA2CA1ALDH1A1
SCHEMBL7513873 0.80 GPR55 (0.67) CA12CA9CA2CA1ALDH1A1
SCHEMBL5934958 0.79 NPC1 (0.75) CA2CA1MAOBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8168796-B2 Fluorescent agent having ethynyl group NIPPON CHEMICAL WORKS CO., LTD. (JP) 2012-05-01 US disclosed
US-20100298573-A1 FLUORESCENT AGENT HAVING ETHYNYL GROUP NIPPON CHEMICAL WORKS CO., LTD (JP) 2010-11-25 US disclosed
US-20100048604-A1 Ligands for Aldoketoreductases TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2010-02-25 US disclosed
US-20100048604-A1 Ligands for Aldoketoreductases TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2010-02-25 US disclosed
WO-1996012718-A1 NOUVELLES 2-[1-(φ-PHENOXYALCOYLPIPERIDIN-4-YL)AMINOMETHYLENE]-2H-BENZOFURAN-3-ONES SUBSTITUEES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE PIERRE FABRE MEDICAMENT (FR) 1996-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298573-A1 FLUORESCENT AGENT HAVING ETHYNYL GROUP IK, CCNE1, TAS2R45 CA12 3937/4885CA9 3368/4885CA2 3181/4885
US-20100048604-A1 Ligands for Aldoketoreductases AKR1C2, AKR1C1, AKR1B1 CA12 4661/4885CA9 3686/4885CA2 4465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.